Pfizer's stock experienced a 2.66% increase on June 9, 2025, closing at $23.97, marking its second consecutive day of gains.

Morgan Stanley sees brighter skies ahead for stocks thanks to a key bullish indicator—earnings revisions breadth. The metric ...

Union Pacific will host a virtual meeting on June 12 to share insights on its operations and future direction. This event is ...

Olstein Capital Management sprinted ahead by upping its stake in NIKE by 42.2%, now holding 91,000 shares worth $5.78 million ...

Deutsche Bank has dropped the scalpel on Intuitive Surgical, cutting its rating from "Hold" to "Sell" and slashing the price ...

Amgen remains a top contender for value investors looking to buy quality at a discount. The biotech giant boasts a Value ...

Honeywell has closed its $2.16 billion all-cash acquisition of Sundyne, a company known for high-performance pumps and ...

S&P Global has officially acquired TeraHelix, a financial tech firm, in a move aimed at boosting its tech dominance. Though ...

Charles Schwab just earned a much-needed image boost after Redburn Atlantic upgraded its rating from "Sell" to "Neutral." ...

Prospect Financial Services LLC dipped its toe into Goldman Sachs waters, grabbing 460 shares worth around $251,000. While ...

RTX is amping up its role in aircraft electrification with Collins Aerospace launching two new facilities in Europe. These ...

NextEra Energy’s stock is showing sparks of life, gaining over 5% in the past month and charming cautious investors back to ...